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Abstract
Background: For clinical and epidemiological reasons, it is interesting to diagnose non-falciparum
malaria to the species level. This retrospective study assessed the performance of the SD BIOLINE
Malaria Antigen Pv test (FK70), a two-band immunochromatographic test detecting Plasmodium
vivax-specific lactate dehydrogenase, on samples of international travellers in a non-endemic setting.
Methods: Stored blood samples from international travellers suspected of malaria were used, with
microscopy corrected by PCR as the reference method. Samples infected by Plasmodium vivax (n =
100), Plasmodium falciparum (n = 75), Plasmodium ovale (n = 75) and Plasmodium malariae (n = 25)
were included, as well as 100 malaria-negative samples. End points were sensitivity, specificity,
inter-reader reliability and reproducibility.
Results: The overall sensitivity of the FK70 for the diagnosis of P. vivax was 88.0% (95% confidence
interval (CI): 83.6% – 90.3%). For parasite densities > 500/μl, a sensitivity of 97.2% (CI: 92.6% –
99.1%) was obtained. Specificity was 98.5%, with 4 out of 75 P. falciparum samples testing positive.
None of the P. ovale samples tested positive. Nearly two-thirds (57/88, 64.7%) of positive P. vivax
samples showed faint or weak line intensities, with stronger line intensities at higher parasite
densities. The test showed excellent reproducibility and reliability for test results and line
intensities (kappa values exceeding 0.98 and 0.87 respectively).
Conclusion: The FK70 test performed well in diagnosing P. vivax infections in a non-endemic
reference setting. It can be of added value to microscopy in species differentiation of malaria
infections, especially at parasite densities > 500/μl.
Background
Malaria is a condition that requires prompt diagnosis, for
which microscopy is considered as the reference standard.
Although cheap, reliable and available on an instant base,
microscopy has its limitations. For instance, in resource-
limited centres, there are problems of equipment, training
and workload, whereas in non-endemic countries, labora-
tory staff may lack sufficient exposure to malaria positive
samples resulting in low expertise [1,2]. Malaria rapid
diagnostic tests (RDTs) have proven to be a valuable
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adjunct to microscopy. The tests initially developed
included a test control line and a Plasmodium falciparum-
specific line targeting histidine-rich protein-2 (HRP-2) or
P. falciparum-specific parasite lactate dehydrogenase
(pLDH). These so-called two-band tests only detect P. fal-
ciparum. The three-band test, engineered later, comprises
a third line for detection of an antigen common to the
four Plasmodium species, such as pan Plasmodium-specific
pLDH or aldolase. These RDTs still only distinguish
between infections due to P. falciparum (or a mix of P. fal-
ciparum and one or more of the non-falciparum species) on
the one hand, and infections with any of the non-falci-
parum species on the other hand. Although monoclonal
antibodies directed to Plasmodium vivax-specific pLDH
(Pv-pLDH) have been developed, RDTs addressing this
target have undergone only limited evaluation [3,4].
The SD FK70 Malaria Antigen Pv test (05-FK70-02-0,
Standard Diagnostics, Hagal-Dong, Republic of Korea),
further referred to as FK70, is a two-band RDT that targets
P. vivax-specific pLDH. This test was evaluated as part of
an accreditation process in the laboratory.
Methods
Study design
In this retrospective study, the FK70 was evaluated against
a collection of stored samples obtained from interna-
tional travellers. Tests were carried out in the reference
laboratory of the Institute of Tropical Medicine (ITM) Ant-
werp, Belgium.
Patients and samples
Samples were selected from a collection of EDTA-blood
samples stored at -70°C and obtained from patients pre-
senting at the outpatient clinic of ITM. The patients were
international travellers and, to a lesser extent, immigrants
returning from visits to their native countries. In addition,
samples sent by Belgian laboratories to ITM in the scope
of the national reference function were included. A repre-
sentative number of samples were selected (n = 375),
including the four malaria species with varying parasite
densities and representative geographic distribution.
Reference method
All samples were analysed by microscopy and real-time
polymerase chain reaction (PCR). In case of discordant
results, microscopy was corrected by PCR as the reference
method. Standard microscopy was performed on thick
blood films of all samples to diagnose malaria and to
assess parasite density, and on thin blood films of positive
samples to define the Plasmodium species. Thick blood
films were stained with Giemsa 3.5% (Merck, KGmA,
Darmstadt, Germany) (pH = 8.0) for 20 minutes, thin
films with May-Grünwald Giemsa. The slides were exam-
ined by light microscopy using a × 500 magnification,
according to the standard procedure at ITM. Parasite den-
sity was assessed by counting the number of asexual para-
sites against 200 white blood cells in a thick film,
converting this to parasites/μl using the actual count or
the standard of 8,000 white blood cell/μl [2].
Real-time PCR analysis was adapted from Rougemont et al
[5] and had been validated against as part of ISO15189
accreditation. DNA of all 375 samples was extracted with
a QIAamp DNA minikit (Qiagen Benelux, Venlo, the
Netherlands) using the same set of primers and species-
specific probes (Biolegio, Nijmegen, the Netherlands),
with reporters and quenchers adapted to the dye channels
of the Cepheid Smart Cycler II device (Lucron Bioprod-
ucts, De Pinte, Belgium). Two PCR reactions were run in
parallel, a duplex reaction to detect P. falciparum and P.
vivax and another reaction for P. ovale and P. malariae. In
the first reaction, the 25 μl reaction mix contained 5 μl
DNA, 1× Quantitec mix (Qiagen Benelux), 200 nM for-
ward and reverse primer, 100 nM falciparum probe and
200 nM vivax probe. In the second reaction, besides 5 μl
template DNA and 1× Quantitec mix (Qiagen Benelux),
500 nM forward and reverse primer, 320 nM ovale probe,
200 nM malariae probe and 1 mM MgCl2 were added. The
PCR programme consisted of an initial step of 15 min at
95°C followed by 50 cycles of 5 sec at 95°C, 30 sec at
58°C and finally 30 sec at 72°C.
Test platform
The FK70 is a lateral flow immunochromatographic RDT
in a cassette format. Two lines are present, a control line,
which indicates whether the test is valid, and a Pv-pLDH
line. According to the manufacturer's instructions, any vis-
ible Pv-pLDH line should be considered as positive, and
results are expressed as positive or negative for P. vivax.
For the evaluation, test kits of two different lot numbers
were used, RDT7001 and BD7001 with expiry dates of
12.08.09 and 27.08.09 respectively.
Test procedure
Tests were performed according to the instructions of the
manufacturer, except that samples (5 μl) were loaded with
a transfer pipette (Finnpippette, Helsinki, Finland)
instead of the plastic loop supplied by the manufacturer
and that a scoring system was used to assess the intensity
of the Pv-pLDH line. In case the control line did not
appear, the result was interpreted as invalid and the test
was repeated. In order to score Pv-pLDH line intensities,
the scoring system of Bell and co-workers [6] was applied
and defined five categories: none (no line visible), faint
(barely visible line), weak (paler than the control line),
medium (equal to the control line) or strong (stronger
than the control line). To assure timely readings, tests
were carried out in time-controlled batches of ten sam-Malaria Journal 2009, 8:129 http://www.malariajournal.com/content/8/1/129
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ples. Readings were performed by three subsequent read-
ers, of whom the one who performed the test procedure
invariably was the first. Readers were blinded to the results
of microscopy and to each others' readings. Readings were
carried out at daylight assisted by a standard electricity
bulb, between 20 and 30 minutes (but not beyond) after
application of the sample and buffer. The results of the
readings considered were based on consensus agreement,
which means that the same result was observed by at least
two out of three different readers. When there was no con-
sensus, results of the first reader were considered. Inter-
reader reliabilities were assessed for the test results
expressed as positive and negative readings as well as for
the Pv-pLDH line intensity readings. To assess reproduci-
bility, a panel of 25 samples (including 20 P. vivax sam-
ples, four P. falciparum samples and one P. ovale sample)
was tested on three successive occasions.
Statistical analysis
True positive results were defined as those with a Pv-
pLDH line visible in samples with P. vivax seen at micros-
copy, and true negative results as those with no Pv-pLDH
line visible in microscopy-negative samples and in sam-
ples with other Plasmodium species. False-negative sam-
ples were identified as those with a microscopic diagnosis
of P. vivax, but no Pv-pLDH line visible, and false-positive
samples as microscopic negative samples and samples
with non-vivax Plasmodium showing a Pv-pLDH line.
From these categories sensitivity and specificity were cal-
culated with 95% confidence intervals (C.I.). Reliabilities
for positive and negative readings and line intensities
were calculated as percentage agreements for all three
readers and kappa values for each pair of readers. Differ-
ences between proportions were tested for significance
using the chi-square test or, in case of small sample sizes,
a two-tailed Fisher's exact test. A p-value < 0.05 was con-
sidered as significant. Associations between line intensity
readings and parasite densities were assessed for strength
of association with Cramer's V for categorical variables.
Ease of use
Three experienced laboratory technicians scored the ease
of use of the FK70 test and the clarity of manufacturer's
instructions with a standardized list.
Ethical review
The study was reviewed and approved by the Institutional
Review Board of ITM and by the Ethical Committee of
Antwerp University, Belgium.
Results
Sample collection
Out of 1,324 stored samples of ITM, 375 samples were
selected, of which 49 samples were sent by Belgian labo-
ratories to ITM for second opinion. The samples were col-
lected from December 1995 to November 2007.
According to microscopy and after correction for PCR
analysis, 100 of these samples were positive for P. vivax,
75 for P. ovale, 75 for P. falciparum and 25 for P. malariae.
The results of microscopy were corrected in 11 out of 375
(2.9%) samples and were uniquely related to P. vivax – P.
ovale mismatches: 4 out of 75 (5.3%) and 7 out of 100
(7.0%) samples that had been categorised as P. vivax and
P. ovale by the original microscopy were identified as P.
ovale and P. vivax respectively by PCR. The microscopic
identification of all P. falciparum, and P. malariae samples
as well as the results of microscopy-negative samples were
confirmed by PCR.
In addition, 100 microscopic and PCR negative samples
of symptomatic travellers were included in the panel. The
majority of the P. vivax samples had been acquired in Asia.
Invalid test results
Two of the 375 samples gave invalid results at initial test-
ing. After application into the respective well, neither the
blood nor the buffer started to migrate. Upon repetition,
tests performed well.
Sensitivity and specificity
Table 1 lists test characteristics matched with species iden-
tification and parasite density. The sensitivity at parasite
densities > 500/μl was 97.2% (Confidence Interval (CI):
92.6% – 99.1%) but was less at lower parasite densities <
500/μl (64.3%, p < 0.001), with 10 out of 12 false nega-
tive samples occurring in this category. Challenged with
other Plasmodium species and negative samples, the FK70
showed a specificity of 98.5%, with 4 out of 75 (5.3%) P.
falciparum samples showing cross-reactions. Of interest is
that none out of 75 P. ovale samples tested positive.
Line intensities
Table 2 lists the Pv-pLDH line intensities matched to spe-
cies identification and parasite density. Nearly two-thirds
(57/88, 64.7%) of all positive P. vivax samples generated
faint or weak line intensities. These occurred not only at
low parasite densities (< 500/μl), but also in 8/11 samples
and 31/61 samples of parasite densities between 501–
1,000/μl and > 1,000/μl respectively. Line intensity read-
ings were significantly related to parasite densities with a
substantial correlation (Cramer's V = 0.5633, p < 0.001),
but there was considerable overlap between categories.
Inter-reader reliability
Inter-reader reliability for positive and negative test results
was high, with 99.2% agreement between the three read-
ers and kappa values exceeding 0.98 for each pair of read-
ers. Two samples of P. vivax with parasite densities of 82
and 230/μl were reported as negative by one reader whileMalaria Journal 2009, 8:129 http://www.malariajournal.com/content/8/1/129
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Table 1: Test characteristics of the FK70
Species and parasite density 
(asexual parasites/μl)
Numbers tested Numbers tested positive by 
FK70
Sensitivity % (95% CI) Specificity % (95% CI)
P. vivax, 0–500/μl2 8 1 8 6 4 . 3
(51.0 – 72.3)
P. vivax, 501–1,000/μl 11 11 100.0
(78.8 – 100.0)
P. vivax, > 1,000/μl6 1 5 9 9 6 . 7
(91.3 – 99.0)
P. vivax, all samples combined 100 88 88.0
(83.6 – 90.3)
Other Plasmodium species 175 4 98.5
(96.9 – 99.4)
P. falciparum 75 4
P. ovale 75 0
P. malariae 25 0
Malaria negative samples 100 0
Test characteristics of the FK70 matched with species and parasite density, PCR-corrected microscopy as the reference method (n = 375).
Table 2: Line intensities of the Pv-PLDH line
Consensus readings of Pv-pLDH line*
Species and parasite density Negative Faint Weak Medium Strong Total
P. vivax 0–500/μl1 0 4 1 4 2 8
P. vivax 501–1,000/μl1 7 2 1 1 1
P. vivax > 1,000/μl2 4 2 7 1 7 1 1 6 1
P. falciparum 71 4 75
P. ovale 75 75
P. malariae 25 25
Malaria negative samples 100 100
Total 283 9 52 19 12 375
FK70 line intensity of the Pv-pLDH line for the different parasite densities
* Consensus Readings: line intensity as read by at least two out of three readersMalaria Journal 2009, 8:129 http://www.malariajournal.com/content/8/1/129
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the other two readers reported them as faint; an additional
sample with a parasite density of 10,556/μl was reported
as faint by two readers and as negative by the third one.
Reliability for Pv-pLDH line intensity readings was also
high, with an overall agreement of 94.2% and kappa val-
ues between the different pairs of readers of 0.87, 0.88 and
0.92 respectively. For strong intensities, all readings were
identical. Less consistent readings were obtained for other
intensities, but discordances between two readers were
always within one category of difference.
Reproducibility
Test results and Pv-pLDH line intensity readings were
reproducible. Consistent line intensity readings for all
readers upon three times repetition were obtained for 12
of the 25 samples. For 10 other samples, discordances
occurred only within one category of difference in line
intensity. The three remaining samples showed differ-
ences in more than one category of difference, with nega-
tive readings, faint and/or weak readings.
Analysis of discordant results
For sixteen samples, the FK70 and PCR-corrected micros-
copy provided discordant results. Twelve P. vivax samples
tested negative and four P. falciparum samples tested pos-
itive. The false-negative P. vivax samples showed no par-
ticular geographic distribution and most of them had low
parasite densities (< 500/μl) (Table 2). The four false pos-
itive P. falciparum samples showed weak line intensities;
they were acquired in the Cameroon, Guinea, the Demo-
cratic Republic of the Congo, and Nigeria (the latter two
in autochthonous native Africans) and had parasite densi-
ties of 7,000, 158,000, 264,000 and 1,000,000/μl, respec-
tively. All samples gave identical results upon retesting
except for a single P. falciparum sample (with parasite den-
sity of 7,000/μl) that was negative upon retesting. Real-
time PCR for all four samples was conclusive for a single
species P. falciparum infection. The samples represented 3/
16 samples with parasite densities above 100,000/μl and
1/59 samples with parasite densities lower than 100,000/
μl (p < 0.05).
Ease of use
The FK70 was scored as practical and easy in use and the
instructions were scored as clear and simple to perform by
all three technicians.
Discussion
This retrospective study demonstrated that the two-band
FK70 test performed well for the detection of P. vivax in a
non-endemic reference setting. The FK70 was scored as
easy-to-use and showed an overall sensitivity and specifi-
city of 88.0% and 98.5% respectively, with excellent relia-
bility and reproducibility.
Several limitations of this study have to be considered. Its
retrospective design precluded exploration of discrepant
results, and although the representative malaria negative
control samples (i.e. samples of symptomatic interna-
tional travellers), the test was not challenged with samples
that are known to cause false positive results such as those
presenting the rheumatoid factor [7]. Next, calibrated
transfer pipette was used instead of the manufacturer's
transfer device, thereby bypassing a possible error of the
kit's application loop. An effect of storage of the samples
on the test results cannot be excluded, but seems to be
unlikely, as observed similar patterns of test results and
Pv-pLDH line intensities on fresh samples analysed pro-
spectively after introduction of the FK70 in the ITM
malaria reference laboratory. Finally, it should be noted
that the present findings apply to a non-endemic refer-
ence setting and should not be as such extrapolated to
field settings: for instance, reported sensitivities of RDTs
tend to be lower in field settings as compared to reference
settings due to better test conditions in the latter [3,8].
Likewise, trained lab technicians generally tend to score
tests and instructions more favourably than less trained
end-users in remote settings, who may experience more
practical difficulties when handling the RDTs [9].
It is difficult to compare the present findings to the
reported literature. Although RDTs have been extensively
evaluated for the diagnosis of P. falciparum malaria, their
ability to detect the other Plasmodium species is less docu-
mented. Most studies have investigated small numbers of
the non-falciparum species, resulting in low precisions and
explaining in part for the wide range in reported sensitiv-
ities [3,10]. Adding to the difficulties are the evolutions in
proprietary compositions and brand names of RDTs, with
continuous releases of improved designs as well as well-
studied products withdrawn from the market [11]. The
World Health Organization (WHO) lists RDT manufac-
turers and distributors online [12], but it is not clear from
the list whether in case a particular RDT detects P. vivax by
Pv-pLDH or by pan-Plasmodium-pLDH. According to the
literature, the DBEST One Step Malaria Test (AmeriTek,
Everett, WA, USA) and the FK70 are at present the only
marketed two-band RDTs that specifically detect P. vivax.
In general, sensitivities of three-band RDTs for the detec-
tion of P. vivax tend to be somewhat lower than presently
described for the two-band FK70. As an example, com-
piled sensitivity for the BinaxNOW kit has been calculated
as 69.6% [3], and reported sensitivities for other kits range
from 1.5% to 97% [3,13]. Decreasing sensitivities at para-
site densities below 5,000/μl and particularly below 500/
μl are reported for all kits [4,14].
Two previous studies assessed the performance of the
FK70 in a P. vivax-endemic setting. In a prospective clini-
cal study, Lee and co-workers demonstrated sensitivityMalaria Journal 2009, 8:129 http://www.malariajournal.com/content/8/1/129
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and specificity of 96.4% and 98.9% respectively [15].
However, they did not include data on parasite densities
and the control group only consisted of malaria-negative
samples. Likewise, Kim and co-workers found in a pro-
spective study an overall sensitivity of 93.4% with lower
sensitivities at low parasite densities, albeit somewhat
higher as compared to those found in the present study.
Among asymptomatic patients and international travel-
lers with P. falciparum infections, they found no false-pos-
itive reactions. Compared side-by-side, their results for the
FK70 were in line with those obtained with the three-band
OptiMAL test (Diamed, Cressier, Switzerland), which
detects P. vivax through a pan-Plasmodium-pLDH anti-
body [16]. In contrast to both studies, the FK70 was chal-
lenged with a large number of non-vivax species, reflecting
more appropriately a travel clinic setting. Unlike the study
of Kim and co-workers, this study demonstrated cross-
reactions with the Pv-pLDH line in four P. falciparum sam-
ples: these samples were obtained in travellers returning
from Africa, and co-infection with P. vivax was not dem-
onstrated by PCR-analysis. As the presently used PCR
analysis had been validated with large numbers of the
four main Plasmodium species that mixed infection with P.
vivax is extremely unlikely and an immunological cross-
reaction has to be concluded. Of note is that the three
samples in which this cross-reaction was found reproduc-
ible had parasite densities exceeding 100,000/μl.
The Pv-pLDH line intensities in the present study were
reproducible and reliable but most readings were scored
as faint or weak. As noted above, this might be caused by
a decrement of antigen activity during storage [3], but this
phenomenon was also demonstrated in recently stored
samples is also noted in prospectively assessed samples at
the ITM reference laboratory. Further studies are to be
done in order to confirm and document this observation.
Faint test lines are a frequently described problem, which
may be caused by the fact that the test line is much nar-
rower than the control line [17,18]. The phenomenon is
important especially in field conditions: interpretation of
faint positive lines as negative test results was found the
most common mistake made by community health care
workers even when provided with adapted job aids
[19,20] and problems can be expected when reading RDTs
during evening and night shifts, particularly for readers
with poor visual capacities [21].
In our hands, the FK70 proved to be an easy-to-use test.
The package insert was scored as clear and informative.
The additional job aids is based on the firstly developed
WHO generic version of the job aids [22] with easily visi-
ble and readable instructions.
Which is the place of a RDT targeting uniquely P. vivax?
Malaria caused by P. vivax is no longer considered as a
mild infection, and compiled evidence has demonstrated
complicated infections in endemic countries as well as in
returned travellers [23,24]. Plasmodium vivax is further
notorious because of its high transmissibility, which
makes it more difficult to eradicate as compared to P. fal-
ciparum [25]. It has a tendency to relapse (for which pri-
maquine therapy is needed), and chloroquine resistant
strains are reported from various parts in the world [26-
28]. As to its epidemiology and geography, it should be
noted that P. vivax unexpectedly has been recovered from
travellers returning from Central-Africa, where it is how-
ever rarely found in indigenous populations, due to their
lack of the Duffy antigen [29]. In the non-endemic setting,
the microscopic differentiation between P. vivax and P.
ovale is notoriously difficult [4], with 14 tot 42% labora-
tories participating to external quality assessments confus-
ing the one species with the other [30]. The rare and even
decreasing trends of P. vivax and P. ovale infections in
returned travellers contribute to the difficulty of correct
species identification [31]. In view of these difficulties,
kits such as the FK70 may be a useful aid for the instant
differential diagnosis of Plasmodium species. The afforda-
ble price, long shelf life and favourable storage conditions
of the kit allow purchase for incidental use. At present, the
FK70 is used in our laboratory as part of the work-up of
samples microscopically suspected for P. vivax and/or P.
ovale. In areas where P. vivax is endemic and occurs as a
single infection, a P. vivax specific RDT can be of value
because it is – at an better accuracy – cheaper than a three-
band RDT [32,33]. In areas where P. vivax and P. falci-
parum are co-circulating, it can distinguish those infec-
tions that require treatment with primaquine [3].
However, in view of the potential cross-reaction of P. fal-
ciparum, the FK70 should not be used the initial or unique
screening test in this situation as an occasional concurrent
or single P. falciparum infection risks to be overlooked.
Conclusion
In conclusion, the FK70 proved to be easy-to-use and
accurate and reliable for the diagnosis of P. vivax among a
panel of samples of symptomatic international travellers.
It is a useful adjunct to microscopy in non-endemic set-
tings. Lower sensitivities at parasite densities below 500/
μl and occasional cross-reactions of P. falciparum should
be taken into account and further prospective investiga-
tions should be done to explore the Pv-pLDH line inten-
sities, especially when considering the use of the FK70 in
a field setting.
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